Organic Heat Exchangers

Activities: Manufacturing

Trending Articles

  1. Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to...
  2. The IND advantage: why early derisking is a strategic imperative for complex biologics As biologics grow more complex, early identification and the mitigation of manufacturability, stability and immunogenicity risks have become the critical factor separating...
  3. Redefining safety, efficiency, and sustainability: SCHOTT Pharma launches next generation polymer syringe system A new cap design for prefillable polymer syringes provides tamper evidence at the individual syringe level, significantly reducing the risk of drug waste and ensuring patient...
  4. You need to be a subscriber to read this article.
    Click here to find out more.
    ADC funding, spatial biology investment and haematology M&A signal biopharma pipeline momentum From a $86.6m Series B for first-in-class ADCs to a $1.25bn haematology acquisition, this week's deals reflect sustained biopharma investment in next-generation therapeutic...
  5. Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and...

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Manufacturing

EnergiVault trial delivers peak performance

Full-scale testing of the EnergiVault cold thermal energy storage system from Organic Heat Exchangers (O-Hx) has seen performance exceed expectations in areas including peak load support, resilience and reliability
Subscribe now